Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does neoadjuvant versus adjuvant systemic treatment improve outcomes in breast cancer?

Nature Clinical Practice Oncology volume 2, pages 342–343 (2005)Cite this article

boxed-textMauri D et al. (2005) Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97: 188–194

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hamilton A and Hortobagyi G (2005) Chemotherapy: what progress in the last 5 years? J Clin Oncol 23: 1760–1775

    Article  CAS  Google Scholar 

  2. Buzdar AU et al. (2005) Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 23: 3676–3685

    Article  CAS  Google Scholar 

  3. Osborne CK and Schiff R (2005) Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol 23: 1616–1622

    Article  CAS  Google Scholar 

  4. Van't Veer LJ et al. (2005) Gene expression profiling of breast cancer: a new tumor marker. J Clin Oncol 23: 1631–1635

    Article  CAS  Google Scholar 

  5. Roukos DH et al. (2003) Perspectives and risks of breast-conservation therapy for breast cancer. Ann Surg Oncol 10: 718–721

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Surgical Oncology Research Unit,

    Dimitrios H Roukos & Angelos M Kappas

  2. Department of Surgery at Ioannina University School of Medicine, Greece

    Dimitrios H Roukos & Angelos M Kappas

Authors
  1. Dimitrios H Roukos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angelos M Kappas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dimitrios H Roukos.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Glossary

PRIMARY MEDICAL THERAPY

Treatment given to reduce tumor size prior to surgery, which may include chemotherapy or radiotherapy; a synonym for neoadjuvant therapy

AC

Adriamycin with cyclophosphamide

REAL-TIME POLYMERASE CHAIN REACTION

A method based on the polymerase chain reaction that is used to quantify exact levels of messenger RNA in tissues and cells

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roukos, D., Kappas, A. Does neoadjuvant versus adjuvant systemic treatment improve outcomes in breast cancer?. Nat Rev Clin Oncol 2, 342–343 (2005). https://doi.org/10.1038/ncponc0222

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0222

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing